Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial
2008712 citationsNR Williams et al.The Lancet Oncologyprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of NR Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by NR Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites NR Williams more than expected).
This network shows the impact of papers produced by NR Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by NR Williams. The network helps show where NR Williams may publish in the future.
Co-authorship network of co-authors of NR Williams
This figure shows the co-authorship network connecting the top 25 collaborators of NR Williams.
A scholar is included among the top collaborators of NR Williams based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with NR Williams. NR Williams is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Vaidya, Jayant S., Max Bulsara, Samuele Massarut, et al.. (2015). Whole breast radiotherapy does not affect growth of cancer foci in other quadrants: results from the TARGIT A trial. UCL Discovery (University College London).1 indexed citations
3.
Keshtgar, Mohammed, NR Williams, Tammy Corica, et al.. (2013). Cosmetic outcome is better after intraoperative radiotherapy compared with external beam radiotherapy: An objective assessment of patients from a randomized controlled trial. UCL Discovery (University College London).1 indexed citations
4.
Keshtgar, Mohammed, et al.. (2011). Significantly Better Cosmetic Outcome After Intraoperative Radiotherapy Compared With External Beam Radiotherapy for Early Breast Cancer: Objective Assessment of Patients From a Randomized Controlled Trial. UCL Discovery (University College London).4 indexed citations
5.
Baum, M, Jayant S. Vaidya, Mohammed Keshtgar, et al.. (2010). TARGIT (TARGETED INTRA-OPERATIVE RADIOTHERAPY FOR EARLY STAGE BREAST CANCER): RESULTS FROM THE TARGIT A RANDOMIZED CONTROLLED TRIAL. UCL Discovery (University College London).1 indexed citations
6.
Williams, NR, et al.. (2008). Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. The Lancet Oncology. 9(1). 45–53.712 indexed citations breakdown →
7.
Williams, NR, et al.. (1994). ACTIVATION OF TRANSFORMING GROWTH-FACTOR-BETA IS INVERSELY CORRELATED WITH 3 MAJOR RISK-FACTORS FOR CORONARY-ARTERY DISEASE - LIPOPROTEIN(A), LDL-CHOLESTEROL AND PLASMINOGEN-ACTIVATOR INHIBITOR-1. UCL Discovery (University College London).1 indexed citations
8.
Galea, M.H., et al.. (1992). Traumatic pneumatocele. Journal of Pediatric Surgery. 27(12). 1523–1524.16 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.